LYPD3 and head and neck squamous cell carcinoma: To evaluate the clinical relevance of the miR-151-5p/LYPD3 axis, we conducted in situ hybridization histochemistry (ISH) and immunohistochemistry (IHC) staining on a clinical cohort comprising 137 HNSCC specimens.